Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism
By L. Linkins, P. Choi, J. Douketis. Annals of Internal Medicine, 2003
816 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/870f9ba286e2bd678fbc70d8ce82c204a236866d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Internal Medicine
Citations in the corpus
- Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy (2008, background): “0% per year,(3,4,6,12) with an estimated case-fatality rate of 13%.(13) Given that the long-term risk of fatal hemorrhage appears to balance the risk of fatal recurrent pulmonary embolism among patients with an unprovoked venous thromboembolism, clinicians are unsure if continuing oral anticoagulati”